Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000200413 | SCV000250461 | uncertain significance | not provided | 2018-10-25 | criteria provided, single submitter | clinical testing | The R543C variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The R543C variant was not observed at a significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This substitution occurs at a position within the EGF-like 9 domain that is conserved across mammalian species. The R543C variant is a non-conservative amino acid substitution, as an arginine is replaced with a cysteine residue, possibly affecting disulfide bonds and impacting protein structure. In silico analyses predict this variant is probably damaging to the protein structure/function. However, no missense mutations in nearby residues have been reported. This variant was found in JAG1 |
Labcorp Genetics |
RCV001054389 | SCV001218701 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2022-08-15 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000200413 | SCV003813879 | uncertain significance | not provided | 2021-03-09 | criteria provided, single submitter | clinical testing |